SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Long‐term survival in transfusion recipients in Sweden, 1993
2 references·7 citing·38 second hop
Long‐term survival in transfusion recipients in Sweden, 1993 (2001)Long‐term survival in transfusion recipie…Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood (1997)Cost‐effectiveness of expande…Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Declining value of alanine am…BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands (2009)BLOOD DONORS AND BLOOD COLLEC…Cost‐effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands (2008)Cost‐effectiveness of additio…Cost-Effectiveness of HIV Screening of Blood Donations in Accra (Ghana) (2008)Cost-Effectiveness of HIV Scr…Who uses blood? (2004)Who uses blood?Importância da avaliação sorológica pré-transfusional em receptores de sangue (2004)Importância da avaliação soro…Uses and sources of data on long-term survival after blood transfusion (2003)Uses and sources of data on l…Transfusion hazard reporting: powerful data, but do we know how best to use it? (2002)Transfusion hazard reporting:…Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Health-State Utilities and Quality of Life in Hepatitis C Patients (2003)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Transfusion sanguine : en toute sécurité d’approvisionnement (2015)Cost effectiveness of adding nucleic acid testing to hepatitis B , hepatitis C , and human immunodeficiency virus screening of blood donations in Z imbabwe (2016)Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China (2024)Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis (1998)Clinical Decision Analysis (1980)Donor Transaminase and Recipient Hepatitis (1981)EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES (1998)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Preference-Based Measures in Economic Evaluation in Health Care (2000)Clinical decision analysis (2005)Reducing risks in blood transfusion: process and outcome (1996)Haemovigilance around the world (2002)Work of the European Haemovigilance Network (EHN) (2004)America finds hemovigilance! (2007)Hemovigilance in developing countries (2010)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)The Risk of Transfusion-Transmitted Infection (1992)Estimated risk of HIV transmission by blood transfusion in Kenya (2001)Competências da enfermeira para a triagem clínica de doadores de sangue (2011)Pre‐donation deferral of blood donors in a Brazilian blood bank: a 10‐year experience (2019)HIV, HTLV, and Hepatitis B and C Infection in Blood Donors in Bahia, Brazil from 2008 to 2017 (2022)Epidemiology of blood transfusion (1994)The annual cost of blood transfusions in the UK (2003)World Development Report 1990. (1990)The Risk of Transfusion-Transmitted Viral Infections (1996)Net Health Benefits (1998)Transmission of HIV Through Blood – How To Bridge the Knowledge Gap (2011)Cost‐effectiveness and budget impact of whole blood pathogen reduction in Ghana (2021)The Markov Process in Medical Prognosis (1983)Equity and the economic evaluation of healthcare (2001)A review and critique of modelling in prioritising and designing screening programmes (2007)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Health economics of blood transfusion safety – focus on sub-Saharan Africa (2009)Residual risk and waste in donated blood with pooled nucleic acid testing (2016)Robust Postdonation Blood Screening Under Prevalence Rate Uncertainty (2017)
this work references cited by second hop

References

  • 1997Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood130 cited
  • 1995Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study124 cited

Cited by

  • 2004Importância da avaliação sorológica pré-transfusional em receptores de sangue41 cited
  • 2009BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands31 cited
  • 2002Transfusion hazard reporting: powerful data, but do we know how best to use it?31 cited
  • 2008Cost-Effectiveness of HIV Screening of Blood Donations in Accra (Ghana)23 cited
  • 2008Cost‐effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands22 cited
  • 2003Uses and sources of data on long-term survival after blood transfusion11 cited
  • 2004Who uses blood?8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work